OMERS ADMINISTRATION Corp Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO)

OMERS ADMINISTRATION Corp purchased a new stake in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 40,100 shares of the company's stock, valued at approximately $335,000. OMERS ADMINISTRATION Corp owned approximately 0.08% of Alpha Teknova at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. increased its position in Alpha Teknova by 622.5% in the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after buying an additional 3,791 shares during the period. Mount Lucas Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth $75,000. China Universal Asset Management Co. Ltd. acquired a new stake in Alpha Teknova during the fourth quarter worth $94,000. NewEdge Advisors LLC boosted its stake in Alpha Teknova by 14.3% during the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after buying an additional 1,953 shares in the last quarter. Finally, Barclays PLC bought a new position in shares of Alpha Teknova during the fourth quarter valued at $132,000. 13.81% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Craig Hallum started coverage on Alpha Teknova in a research note on Monday, February 10th. They issued a "buy" rating and a $12.00 price target for the company.

Alpha Teknova Stock Down 4.2%

Shares of NASDAQ TKNO traded down $0.26 during trading hours on Friday, hitting $5.97. The company had a trading volume of 398,237 shares, compared to its average volume of 393,518. Alpha Teknova, Inc. has a 1-year low of $1.16 and a 1-year high of $10.37. The firm's 50 day moving average is $5.94 and its 200-day moving average is $7.09. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $319.04 million, a P/E ratio of -8.07 and a beta of 0.50.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.02. The firm had revenue of $9.60 million for the quarter, compared to analysts' expectations of $9.41 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. On average, analysts expect that Alpha Teknova, Inc. will post -0.58 earnings per share for the current fiscal year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.